Venture Capital

Vyome is set to present promising Phase 2 data for VT-1953, a first-in-class treatment for a debilitating cancer complication with no approved drugs.

In a pivotal move from R&D to commercial scale, Zivo Bioscience partners with industry leader Cyanotech to meet global demand for its unique algal biomass.

This April, families nationwide are walking to fund a new strategy for Lennox-Gastaut Syndrome, aiming to slash diagnosis times and find real cures.

With a $5M private placement, Ubercrete is one step closer to a public listing and revolutionizing the construction industry with its advanced concrete tech.

MTI replaces its Road Tour with an intense, invite-only forum, uniting top regulators and experts to find the next wave of healthcare solutions.

The junior explorer has applied to go public on the CSE, aiming to capitalize on soaring metal prices. But what are the risks and rewards for investors?

As 'forever chemicals' plague South Florida, a new, costly plasma exchange therapy offers a solution. But is it a medical breakthrough or a luxury trend?

President Trump's 100% tariff on imported drugs aims to secure the US supply chain, but the policy's success may hinge on unproven and unverified players.

Biopharma firm GENFIT sees soaring Iqirvo sales and a cash runway past 2028, overshadowing a net loss driven by strategic, non-cash write-downs.

Manufacturers are spending millions on ERP systems with poor results. Discover why a 'process-first' approach is becoming critical for survival and growth.

A new strategic alliance aims to transform media workflows. Learn how advanced AI will change content discovery, personalization, and revenue generation.

Lucid's award-winning Gravity SUV gets a major upgrade, adding standard tech and a new Prestige Package to challenge luxury EV rivals head-on.

Flush with $60M in new funding, the AI code review leader taps Matthew Mulqueen to translate its technical dominance into global enterprise adoption.

Samyang's Buldak returns to Coachella, turning spicy challenges and culinary crawls into a masterclass on marketing to Gen Z and building a flavor empire.

A major lab expansion in Massachusetts aims to slash preclinical timelines for the most promising new cancer treatments, including advanced radiotherapies.

GigaIO sells its core datacenter tech to d-Matrix in a strategic pivot to the booming edge AI market, while d-Matrix gears up to challenge inference giants.

A new partnership links Central Indiana's top pickleball clubs to a Major League Pickleball champion, creating a new path for aspiring pros.

Data storage giant Solidigm's massive investment in its Sacramento campus is creating jobs and developing next-generation hardware for the AI revolution.

As federal agencies scale AI, Cyera's pursuit of the government's top security clearance signals a critical shift to securing data in the age of AI agents.

Khloé Kardashian's Khloud brand expands with new Protein Chips, leveraging celebrity power and a strategic Target partnership to disrupt the snack market.